<DOC>
	<DOCNO>NCT02447900</DOCNO>
	<brief_summary>Proof concept study evaluate safety performance gel marker ( BioXmark ) use image guidance deep inspiration breathhold radiotherapy ( DIBH IGRT ) patient locally advance non-small cell lung cancer ( NSCLC )</brief_summary>
	<brief_title>Marker Guided Breathhold Radiotherapy NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Inclusion criterion Age &gt; 18 year old Histologically confirm nonsmall cell lung cancer ( NSCLC ) Stage T14N13M0 Performance status ≤ 2 Inoperable FEV1 ≥ 1 l Ability hold deep inspiration breathhold &gt; 15 second Accepting treatment Rigshospitalet Eligible concomitant chemoradiotherapy If woman childbearing potential , negative pregnancy test must document Ability understand give information Signed write consent inclusion study Exclusion criterion Prior thoracic radiotherapy Allergy Iodine iodine base contrast In opinion investigator , patient able follow study procedure consider eligible reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>